ZOLLO MASSIMO has a total of 12 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are JOSLIN DIABETES CENTER INC, VERENIGING HET NL KANKER I and DAVID GLADSTONE INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | Italy | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Heterocyclic compounds | |
#8 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Zollo Massimo | 12 |
#2 | Kikuchi Akira | 2 |
#3 | Galeone Aldo | 1 |
#4 | Virgilio Antonella | 1 |
#5 | De Antonellis Pasquale | 1 |
#6 | Spano Daniela | 1 |
Publication | Filing date | Title |
---|---|---|
WO2014045310A1 | Pyrimido[5,4-d]pyrimidine or pyrimidine derivatives compounds and uses thereof in the treatment of cancer | |
EP2503009A1 | Biomarker for detecting circulating tumor cells and related detecting methods and kit | |
WO2007086093A2 | Inhibitors of cell migration mediated by h-prune-gsk-3 complex and uses in antitumoral therapy | |
CA2549291A1 | Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |